ГоловнаArchive of numbers2021Volume 29, issue 2 (107)Multidisciplinary and differentiated approach in the treatment of psychotic disorders with comorbid somatic states
Title of the article Multidisciplinary and differentiated approach in the treatment of psychotic disorders with comorbid somatic states
Authors Oprya Yevgen
Pustovoit Mykhailo
Year 2021 Issue Volume 29, issue 2 (107) Pages 52-56
Type of article Scientific article Index UDK 616.89-036.12-06-085 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V29-is2-2021-9 The article presents the results of a comprehensive clinical and psychopathological study of the features of clinical manifestations of psychotic patients with schizophrenia with somatic disorders. It has been proven that disorders in schizophrenia are associated with a negative clinical-psychopathological and socio-personal prognosis, leading to increase of severity of psychopathological symptoms and a decrease in the level of socio-psychological functioning. The identified features of the clinical course have become the leading target features, a system of multidisciplinary and differentiated approach in the complex therapy of patients taking into account somatic comorbidity has been developed and implemented in practice. The proposed system is a set of activities, including a combination of pharmacotherapeutic, psychoeducational, psychotherapeutic and psychosocial activities, selected taking into account the specifics of the psychopathological process modified by somatic pathology. According to the results of testing, its effectiveness has been proven, and it has been established that its use can significantly improve the condition of patients and their level of socio-psychological functioning, increase the stability of remission and reduce the number of hospitalizations.
Key words schizophrenia, disorders, differentiated approach, multidisciplinary, complex treatment system
Access to full text version of the article pdf download
Bibliography 1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990—2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet; 2018 (https://doi.org/10.1016/S0140-6736(18)32279-7). 2. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annual Review of Clinical Psychology, 2014; 10, 425—438. 3. Lora A et al. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bulletin World Health Organization; 2012: 10.2471 / BLT.11.089284. 4. Physical Health and Schizophrenia / David J. Castle, Peter F. Buckley, Fiona P. Gaughran // Oxford University Press. 2017. 136 p. 5. Belyalov F.I. Treatment of diseases in conditions of comorbidity / F.I. Belyalov; 10th ed. M .: GEOTAR-Media; 2016. 264 p. 6. Bensa Q. Somatic treatments in psychiatry: A descriptive study of laboratory tests and systematic involvement in terms of overall care / Q. Bensa, Y. Auxéméry // Encephale. 2017. Vol. 43 (3). P. 205—211. 7. Maruta N.A. Clinical and psychopathological structure of comorbid mental pathology in patients with schizophrenia / N.A. Maruta, S.A. Yaroslavtsev, E.S. Cherednyakova // Psychiatry, psychotherapy and clinical psychology, 2015. No. 3 (21). S. 68—78. 8. Revenok O.A. Features of concomitant somatic pathology in patients with paranoid schizophrenia / O.A. Revenok, Ya. Yu. Marunkevich // Archives of Psychiatry. 2014. 4 (79). pp. 75—79. 9. Cohen A. Addressing comorbidity between mental disorders and major noncommunicable diseases. Background technical paper to support the implementation of the European Mental Health Action Plan 2013—2020 and the WHO Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016—2025 // World Health Organization. 2017. 44 p. Access mode: http://www.euro.who.int/ru/publications/abstracts/addressing-comorbidity-between-mental-disorders-and-major-noncommunicable-diseases-2017 10. Gerasim’yuk I.G. Reception of schizophrenia and somatic pathology / I.G. Gerasim’yuk // WorldScience. 2018. No. 6 (34). Vol. 5. P.47—49. 11. The problem of multiple somatic and / or mental pathology / А.S. Avedisova, M.O. Zhabin, R.G. Akzhigitov, A.A. Gudkova // Journal of Neurology and Psychiatry. S.S. Korsakov. 2018. Issue. 118 (5). S. 5—13. Access mode: https://doi.org/10.17116/jnevro2018118515 12. Belyalov A.B. Abstracts of psychosomatic medicine / A.B. Belyalov // Rational pharmacotherapy in cardiology. 2017. Issue. 13 (2). P. 221—228. 13. Danilov D.S. Justification of the use of antidepressants in the treatment of schizophrenia (modern view of the problem from the standpoint of evidence-based medicine) / D.S. Danilov, D.O. Magomedova, M.E. Matsneva // Neurology, neuropsychiatry, psychosomatics. 2016. Issue. 8 (1). S. 71—81. 14. Maruta N.A. The problem of comorbidity in modern psychiatry. Theoretical, clinical, therapeutic and organizational aspects / N. A. Maruta // Health of Ukraine. 2013. No. 12. S. 38—39.